DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar wooderino (93.07) Submitted: 10/27/2009 12:15:50 PM : Outperform Start Price: $53.45 DVA Score: +29.60

Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.

Featured Broker Partners


Advertisement